Diarrhoea-predominant irritable bowel syndrome colonic biopsies exhibit tuft cell hyperplasia

被引:0
|
作者
Connolly, M. [1 ]
Aigbologa, J. [1 ]
O'Brien, R. [1 ]
Buckley, M. M. [1 ]
Buckley, J. M. [1 ]
O'Malley, D. [1 ]
机构
[1] Univ Coll Cork, Cork, Ireland
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
52
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Review article: an analysis of safety profiles of treatments for diarrhoea-predominant irritable bowel syndrome
    Lacy, Brian E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (08) : 817 - 830
  • [22] Abnormalities of small bowel and colonic water content in diarrhoea-predominant irritable bowel syndrome: Novel insights from magnetic resonance imaging
    Marciani, L.
    Foley, S.
    Hoad, C. L.
    Campbell, E.
    Totman, J. J.
    Cox, E.
    Gowland, P. A.
    Spiller, R. C.
    GUT, 2007, 56 : A65 - A65
  • [23] Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome
    Leventer, S. M.
    Raudibaugh, K.
    Frissora, C. L.
    Kassem, N.
    Keogh, J. C.
    Phillips, J.
    Mangel, A. W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (02) : 197 - 206
  • [24] Cytokine changes in colonic mucosa associated with Blastocystis spp. subtypes 1 and 3 in diarrhoea-predominant irritable bowel syndrome
    Yakoob, Javed
    Abbas, Zaigham
    Usman, Muhammad Waqas
    Sultana, Aisha
    Islam, Muhammad
    Awan, Safia
    Ahmad, Zubair
    Hamid, Saeed
    Jafri, Wasim
    PARASITOLOGY, 2014, 141 (07) : 957 - 969
  • [25] Effect of rapid colonic transit on stool microbiome and short-chain fatty acids in diarrhoea-predominant irritable bowel syndrome
    BouSaba, Joelle
    Zheng, Ting
    Dilmaghani, Saam
    Johnson, Stephen
    Chen, Jun
    Camilleri, Michael
    GUT, 2024, 73 (02) : 375 - 376
  • [26] DECREASED LACTOBACILLI IN THE ILEAL MUCOSA-ASSOCIATED MICROBIOTA IN DIARRHOEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
    Parkes, G. C.
    Petrovska, L.
    Woodman, I. J.
    Rayment, N. B.
    Hudpsith, B. N.
    Lomer, M.
    Brostoff, J.
    Whelan, K.
    Sanderson, J. D.
    GUT, 2009, 58 : A105 - A106
  • [27] Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations
    Vicario, Maria
    Gonzalez-Castro, Ana M.
    Martinez, Cristina
    Lobo, Beatriz
    Pigrau, Marc
    Guilarte, Mar
    de Torres, Ines
    Mosquera, Jose L.
    Fortea, Marina
    Sevillano-Aguilera, Cesar
    Salvo-Romero, Eloisa
    Alonso, Carmen
    Rodino-Janeiro, Bruno K.
    Soderholm, Johan D.
    Azpiroz, Fernando
    Santos, Javier
    GUT, 2015, 64 (09) : 1379 - 1388
  • [28] Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier
    Martinez, Cristina
    Lobo, Beatriz
    Pigrau, Marc
    Ramos, Laura
    Maria Gonzalez-Castro, Ana
    Alonso, Carmen
    Guilarte, Mar
    Guila, Meritxell
    de Torres, Ines
    Azpiroz, Fernando
    Santos, Javier
    Vicario, Maria
    GUT, 2013, 62 (08) : 1160 - 1168
  • [29] Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review
    Jun-Jie Hou
    Wang, Xin
    Yu-Ming Wang
    Bang-Mao Wang
    CRITICAL REVIEWS IN MICROBIOLOGY, 2022, 48 (06) : 696 - 713
  • [30] Efficacy and safety of Gelsectan for diarrhoea-predominant irritable bowel syndrome: A randomised, crossover clinical trial
    Trifan, Anca
    Burta, Ovidiu
    Tiuca, Nicoleta
    Petrisor, Diana Corina
    Lenghel, Augustin
    Santos, Javier
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (08) : 1093 - 1101